Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19255001 | SAFETY SYRINGE | June 2025 | February 2026 | Allow | 8 | 2 | 0 | Yes | No |
| 19004370 | PRE-FILLED SYRINGE SAFETY DEVICES AND INJECTORS, SYSTEMS, AND METHODS OF USE | December 2024 | August 2025 | Allow | 7 | 2 | 0 | Yes | Yes |
| 18596067 | OPHTHALMIC DEVICE | March 2024 | March 2026 | Allow | 24 | 2 | 0 | Yes | No |
| 18513903 | INTERNAL BALLOON SHEATH | November 2023 | March 2026 | Allow | 28 | 3 | 0 | No | No |
| 18493552 | VASCULAR ACCESS DEVICES WITH INTEGRATED SAFETY FEATURES | October 2023 | November 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18485168 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | October 2023 | September 2025 | Allow | 23 | 2 | 0 | Yes | Yes |
| 18285671 | PRE-FILLED SYRINGE SAFETY DEVICES AND INJECTORS, SYSTEMS, AND METHODS OF USE | October 2023 | December 2024 | Allow | 14 | 2 | 0 | Yes | No |
| 18369325 | Cartilage repair, preservation and growth by stimulation of bone-chondral interface and delivery system and methods therefor | September 2023 | November 2025 | Abandon | 26 | 2 | 0 | No | No |
| 18243008 | MEDICAMENT DELIVERY DEVICE | September 2023 | July 2025 | Allow | 23 | 2 | 0 | Yes | No |
| 18242899 | Injector and Injection Method Therefor | September 2023 | May 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18453423 | CATHETER ASSEMBLY WITH GUIDEWIRE, CATHETER AND PUNCTURE NEEDLE | August 2023 | March 2025 | Allow | 19 | 2 | 0 | Yes | No |
| 18365024 | OCULAR INJECTOR AND METHODS FOR ACCESSING SUPRACHOROIDAL SPACE OF THE EYE | August 2023 | December 2023 | Allow | 4 | 1 | 0 | Yes | No |
| 18222841 | MEDICAMENT DELIVERY DEVICE | July 2023 | October 2025 | Allow | 27 | 3 | 0 | Yes | No |
| 18342443 | INFUSION TUBE SYSTEM AND METHOD FOR MANUFACTURE | June 2023 | August 2024 | Allow | 14 | 1 | 0 | Yes | No |
| 18206515 | OCCLUSION DETECTION DEVICES, SYSTEMS, AND METHODS | June 2023 | January 2026 | Allow | 31 | 3 | 0 | Yes | No |
| 18143844 | APPARATUS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS | May 2023 | May 2025 | Abandon | 25 | 3 | 0 | Yes | No |
| 18309173 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | April 2023 | April 2025 | Allow | 23 | 2 | 0 | Yes | No |
| 18297429 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | April 2023 | November 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18127406 | INFUSION TUBE SYSTEM AND METHOD FOR MANUFACTURE | March 2023 | November 2024 | Abandon | 20 | 1 | 0 | Yes | No |
| 18185710 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | March 2023 | March 2026 | Allow | 36 | 1 | 0 | Yes | No |
| 18023407 | MULTI-STAGE INJECTION DEVICE | February 2023 | February 2026 | Allow | 36 | 0 | 0 | No | No |
| 18109507 | Wearable Injector With Sterility Sensors | February 2023 | June 2025 | Allow | 28 | 1 | 1 | Yes | No |
| 18100845 | SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICES | January 2023 | March 2024 | Allow | 14 | 1 | 0 | Yes | No |
| 18156891 | DEVICES AND METHODS FOR ELECTROTRANSFER | January 2023 | January 2024 | Abandon | 12 | 1 | 0 | No | No |
| 17875031 | Drug Delivery Assembly Including An Actuator | July 2022 | November 2024 | Allow | 27 | 3 | 0 | Yes | No |
| 17869202 | INTERNAL BALLOON SHEATH | July 2022 | August 2023 | Allow | 13 | 1 | 0 | Yes | No |
| 17747566 | OPHTHALMIC DEVICE | May 2022 | November 2023 | Allow | 18 | 2 | 0 | No | No |
| 17739816 | Spacer Assembly for Drug Delivery Device | May 2022 | October 2024 | Allow | 29 | 3 | 1 | No | No |
| 17662041 | HUMIDIFICATION APPARATUS HAVING RFID TAG SENSOR AT PATIENT END OF GAS PATHWAY | May 2022 | October 2025 | Abandon | 41 | 4 | 0 | Yes | Yes |
| 17773309 | VASCULAR RE-ENTRY CATHETER | April 2022 | November 2025 | Abandon | 43 | 5 | 1 | No | No |
| 17730308 | EXTENSION TUBE CLAMP PROVIDING POSITIVE DISPLACEMENT | April 2022 | July 2023 | Allow | 15 | 1 | 0 | Yes | No |
| 17711495 | OCULAR INJECTOR AND METHODS FOR ACCESSING SUPRACHOROIDAL SPACE OF THE EYE | April 2022 | June 2023 | Allow | 14 | 3 | 0 | Yes | No |
| 17683580 | SAFETY SYRINGE | March 2022 | February 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17681768 | Cartilage repair, preservation and growth by stimulation of bone-chondral interface and delivery system and methods therefor | February 2022 | May 2023 | Allow | 14 | 1 | 0 | No | No |
| 17578749 | APPARATUS AND METHODS FOR BIOMIMETIC EXPRESSION OF BREAST MILK | January 2022 | March 2024 | Allow | 26 | 3 | 0 | Yes | No |
| 17566079 | SYRINGE-BASED MICROBUBBLE GENERATOR WITH AN AERATOR | December 2021 | March 2022 | Allow | 3 | 0 | 0 | Yes | No |
| 17549120 | AUTO-INJECTION DEVICE | December 2021 | September 2023 | Abandon | 21 | 1 | 0 | No | No |
| 17542386 | SYRINGE-BASED MICROBUBBLE GENERATOR | December 2021 | August 2023 | Allow | 20 | 1 | 0 | Yes | No |
| 17518139 | MEDICAMENT DELIVERY DEVICE | November 2021 | October 2023 | Allow | 23 | 2 | 0 | Yes | No |
| 17452523 | APPARATUS AND PROCESS FOR PRODUCING CO2 ENRICHED MEDICAL FOAM | October 2021 | July 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17508246 | DUAL CANNULATED SUCTION AND DELIVERY DEVICE | October 2021 | December 2025 | Abandon | 50 | 2 | 0 | No | No |
| 17481435 | CATHETER DELIVERY GUIDEWIRE CLAMP | September 2021 | May 2023 | Allow | 19 | 4 | 0 | Yes | Yes |
| 17468556 | MEDICAL DEVICE | September 2021 | December 2025 | Abandon | 51 | 2 | 0 | No | No |
| 17398535 | INFUSION TUBE SYSTEM AND METHOD FOR MANUFACTURE | August 2021 | February 2023 | Allow | 18 | 1 | 0 | Yes | No |
| 17381950 | OPHTHALMIC DEVICE | July 2021 | March 2022 | Allow | 8 | 1 | 0 | No | No |
| 17421661 | Injection Device | July 2021 | June 2025 | Allow | 47 | 1 | 0 | Yes | No |
| 17299850 | DEVICES AND PROCESSES FOR DELIVERY OF THERAPEUTIC FLUIDS | June 2021 | June 2025 | Allow | 48 | 1 | 0 | Yes | No |
| 17329408 | METHODS FOR OPERATING MODE TRANSITIONS AND RELATED INFUSION DEVICES AND SYSTEMS | May 2021 | December 2022 | Allow | 18 | 0 | 0 | No | No |
| 17323382 | MEDICAMENT DELIVERY DEVICE | May 2021 | October 2023 | Allow | 29 | 2 | 0 | Yes | No |
| 17314412 | CATHETER ASSEMBLY WITH GUIDEWIRE, CATHETER AND PUNCTURE NEEDLE | May 2021 | March 2023 | Allow | 22 | 1 | 0 | Yes | No |
| 17233190 | CAP ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE | April 2021 | March 2026 | Allow | 59 | 5 | 0 | No | No |
| 17231025 | CONTAINER AND DIALYSIS MACHINE COMPRISING A CONTAINER | April 2021 | November 2024 | Abandon | 43 | 2 | 0 | No | No |
| 17208955 | ENDOSCOPIC CANNULA | March 2021 | May 2025 | Allow | 50 | 2 | 0 | Yes | No |
| 17209167 | Tubular Structures with Variable Support | March 2021 | August 2021 | Allow | 4 | 1 | 0 | Yes | No |
| 17277704 | NASOGASTRIC PROBE | March 2021 | June 2025 | Abandon | 51 | 1 | 0 | No | No |
| 17195230 | VASCULAR INSTRUMENT DELIVERY DEVICE AND RELATED SYSTEMS AND METHODS | March 2021 | July 2025 | Allow | 52 | 5 | 0 | Yes | No |
| 17180105 | Wearable Injector with Sterility Sensors | February 2021 | November 2022 | Allow | 21 | 4 | 1 | Yes | No |
| 17180578 | DRUG DELIVERY ASSEMBLY INCLUDING A REMOVABLE CARTRIDGE | February 2021 | August 2021 | Allow | 6 | 2 | 0 | Yes | No |
| 17179188 | FLEXIBLE TIP CATHETER | February 2021 | November 2022 | Allow | 20 | 0 | 0 | Yes | No |
| 17173389 | HEMOSTATIC DEVICES AND METHODS OF USE | February 2021 | May 2024 | Allow | 39 | 4 | 0 | Yes | No |
| 17264256 | Implantable Port Placement System Including Low-Scarring Exterior | January 2021 | November 2025 | Allow | 58 | 5 | 0 | Yes | No |
| 17158396 | SYRINGE-BASED MICROBUBBLE GENERATOR | January 2021 | September 2021 | Allow | 7 | 2 | 0 | Yes | No |
| 17144914 | Oral Mucosal Electroporation Device and Use Thereof | January 2021 | June 2024 | Allow | 41 | 3 | 0 | Yes | No |
| 17126295 | SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICES | December 2020 | October 2022 | Allow | 22 | 0 | 0 | Yes | No |
| 17247395 | INTRAVASCULAR CATHETER INSERTION DEVICE | December 2020 | November 2023 | Allow | 36 | 0 | 0 | Yes | No |
| 17114238 | MEDICAMENT DELIVERY DEVICE | December 2020 | August 2023 | Allow | 32 | 2 | 0 | Yes | No |
| 17114235 | MEDICAMENT DELIVERY DEVICE | December 2020 | September 2024 | Allow | 45 | 5 | 0 | Yes | No |
| 17114241 | MEDICAMENT DELIVERY DEVICE | December 2020 | August 2023 | Allow | 32 | 2 | 0 | Yes | No |
| 15734773 | AN ENTERAL FEEDING DEVICE | December 2020 | August 2024 | Allow | 44 | 2 | 0 | Yes | No |
| 17055905 | QUICK RELEASE CAPSULES | November 2020 | April 2025 | Abandon | 53 | 2 | 1 | No | No |
| 17096845 | SYNERGISTIC FEATURES AND FUNCTIONS RELATED TO OPERATION OF A MEDICATION DELIVERY SYSTEM AND A MEAL TRANSACTION APPLICATION | November 2020 | November 2024 | Allow | 48 | 5 | 0 | Yes | No |
| 17090236 | AUTO-INJECTION DEVICE | November 2020 | September 2021 | Allow | 10 | 3 | 0 | Yes | No |
| 17048260 | SYRINGE | October 2020 | December 2023 | Abandon | 38 | 1 | 0 | No | No |
| 17042144 | FAT SUCTION AND GRAFT SYRINGE HAVING NEGATIVE PRESSURE ADJUSTMENT MEANS | September 2020 | October 2022 | Allow | 25 | 1 | 0 | Yes | No |
| 17032715 | GASKET PRESSING TOOL AND DRUG ADMINISTRATION TOOL USING THE SAME | September 2020 | March 2025 | Allow | 54 | 2 | 1 | No | No |
| 17040431 | DEVICE FOR ADMINISTERING A FLUID | September 2020 | June 2024 | Abandon | 45 | 2 | 0 | No | No |
| 17022936 | Steerable Medical Device Handle | September 2020 | March 2025 | Allow | 54 | 4 | 0 | Yes | No |
| 16969691 | CONTROLLED DISPENSE SYRINGE | August 2020 | April 2023 | Allow | 32 | 2 | 0 | Yes | No |
| 16993062 | CATHETER ADAPTERS | August 2020 | May 2023 | Allow | 33 | 3 | 0 | Yes | No |
| 16932135 | HYPODERMIC DEVICE WITH AN ARRAY OF HYPODERMIC NEEDLES | July 2020 | January 2023 | Abandon | 30 | 4 | 0 | Yes | Yes |
| 16929081 | CLOSED-LOOP GLUCOSE AND/OR INSULIN CONTROL SYSTEM | July 2020 | April 2023 | Abandon | 33 | 1 | 0 | No | No |
| 16910640 | DEVICES AND METHODS FOR DELIVERING A LYOPHILIZED MEDICAMENT | June 2020 | January 2024 | Allow | 43 | 2 | 0 | Yes | No |
| 16905382 | STIMULATION OF CARTILAGE FORMATION USING REDUCED PRESSURE TREATMENT | June 2020 | September 2022 | Allow | 27 | 1 | 0 | No | No |
| 16898905 | PRESSURE CONTROL IN PHACOEMULSIFICATION SYSTEM | June 2020 | September 2022 | Allow | 27 | 1 | 0 | No | No |
| 16898529 | WEARABLE AUTOMATED MEDICATION DELIVERY SYSTEM | June 2020 | April 2023 | Allow | 34 | 2 | 0 | No | No |
| 16771084 | INJECTION DEVICE WITH A REMOTE CONTROL | June 2020 | November 2022 | Allow | 29 | 1 | 0 | Yes | No |
| 16892100 | INFUSION PUMP SYSTEM AND METHODS | June 2020 | January 2023 | Abandon | 31 | 7 | 0 | Yes | No |
| 16890962 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | June 2020 | September 2025 | Abandon | 60 | 2 | 0 | Yes | Yes |
| 16764638 | MEDICAL DELIVERY DEVICE WITH AXIALLY EXPANDABLE DRIVE RIBBON | May 2020 | August 2023 | Allow | 39 | 1 | 0 | Yes | No |
| 16862448 | Cartilage repair, preservation and growth by stimulation of bone-chondral interface and delivery system and methods therefor | April 2020 | December 2021 | Allow | 19 | 2 | 0 | Yes | No |
| 16858686 | CONTAINER ADAPTER FOR REMOVABLY ATTACHABLE SYRINGE | April 2020 | May 2021 | Allow | 13 | 3 | 0 | Yes | No |
| 16849111 | SAFETY SYRINGE | April 2020 | November 2021 | Allow | 19 | 0 | 0 | No | No |
| 16841398 | OCCLUSION DETECTION DEVICES, SYSTEMS, AND METHODS | April 2020 | February 2023 | Allow | 35 | 4 | 0 | Yes | No |
| 16652082 | TEMPER EVIDENT INJECTOR LOCK AND A LOCKING METHOD | March 2020 | May 2022 | Abandon | 25 | 1 | 0 | No | No |
| 16800177 | MEDICAMENT DELIVERY DEVICE | February 2020 | February 2022 | Allow | 23 | 1 | 0 | Yes | No |
| 16793948 | EXTENSION TUBE CLAMP PROVIDING POSITIVE DISPLACEMENT | February 2020 | January 2022 | Allow | 23 | 1 | 0 | Yes | No |
| 16785400 | SYSTEMS AND METHODS FOR ESTABLISHING A NERVE BLOCK | February 2020 | November 2021 | Allow | 21 | 1 | 0 | Yes | No |
| 16636168 | INJECTOR PREMATURE ACTIVATION BLOCKING MECHANISM | February 2020 | April 2022 | Allow | 27 | 1 | 0 | Yes | No |
| 16774213 | INTERNAL BALLOON SHEATH | January 2020 | April 2022 | Allow | 27 | 3 | 0 | Yes | No |
| 16629820 | MULTI-NEEDLE MODULE SUITABLE FOR SKIN PROCEDURE AT SLOPE | January 2020 | February 2022 | Abandon | 26 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SWANSON, LEAH JENNINGS.
With a 12.5% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 19.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SWANSON, LEAH JENNINGS works in Art Unit 3783 and has examined 288 patent applications in our dataset. With an allowance rate of 67.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.
Examiner SWANSON, LEAH JENNINGS's allowance rate of 67.4% places them in the 29% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by SWANSON, LEAH JENNINGS receive 2.98 office actions before reaching final disposition. This places the examiner in the 86% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SWANSON, LEAH JENNINGS is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +37.0% benefit to allowance rate for applications examined by SWANSON, LEAH JENNINGS. This interview benefit is in the 85% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 20.1% of applications are subsequently allowed. This success rate is in the 22% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 21.9% of cases where such amendments are filed. This entry rate is in the 28% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 46.2% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 42% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 63.6% of appeals filed. This is in the 43% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 45.6% are granted (fully or in part). This grant rate is in the 39% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.